Shanghai Yizhong Pharmaceutical Co., Ltd. (SHA:688091)

SHA:688091 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 23, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	10,590	9,655	8,204	10,130	10,043	4,748
Market Cap Growth	43.73%	17.68%	-19.01%	0.86%	111.52%	-
Enterprise Value	10,104	9,170	7,561	9,024	9,008	3,816
Last Close Price	51.55	47.00	39.92	48.83	48.26	22.82
PE Ratio	166.29	150.55	1176.22	62.70	70.31	-
PS Ratio	33.40	30.45	47.28	28.12	42.57	1164.50
PB Ratio	7.25	6.61	5.84	6.92	7.61	4.04
P/TBV Ratio	7.39	6.74	5.87	6.96	7.66	4.07
P/FCF Ratio	-	-	-	130.25	134.09	-
P/OCF Ratio	-	-	208.04	117.03	90.66	-
EV/Sales Ratio	31.87	28.92	43.57	25.05	38.18	935.90
EV/EBITDA Ratio	137.97	125.20	-	53.89	77.72	-
EV/EBIT Ratio	162.78	147.72	-	56.56	82.28	-
EV/FCF Ratio	-	-	-	116.03	120.27	-
Debt / Equity Ratio	-	-	-	0.03	-	0.01
Debt / EBITDA Ratio	-	-	-	0.26	-	-
Debt / FCF Ratio	-	-	-	0.57	-	-
Net Debt / Equity Ratio	-0.33	-0.33	-0.48	-0.82	-0.85	-0.80
Net Debt / EBITDA Ratio	-6.63	-6.63	138.50	-7.14	-9.73	45.91
Net Debt / FCF Ratio	-	-	16.53	-15.38	-15.06	18.03
Asset Turnover	-	-	0.12	0.25	0.19	0.01
Inventory Turnover	-	-	0.36	1.04	1.18	0.05
Quick Ratio	-	-	18.27	13.30	39.18	45.80
Current Ratio	-	-	19.68	13.59	40.17	47.08
Return on Equity (ROE)	4.47%	4.47%	0.49%	11.61%	11.45%	-0.56%
Return on Assets (ROA)	-	-	-0.66%	6.81%	5.36%	-2.31%
Return on Invested Capital (ROIC)	6.36%	7.26%	-3.19%	54.72%	48.57%	-12.41%
Return on Capital Employed (ROCE)	-	-	-1.10%	10.90%	8.30%	-2.30%
Earnings Yield	0.61%	0.66%	0.08%	1.59%	1.42%	-0.08%
FCF Yield	-	-	-0.50%	0.77%	0.75%	-1.09%
Dividend Yield	-	-	-	0.06%	0.43%	-
Payout Ratio	-	-	713.87%	26.87%	0.34%	-
Buyback Yield / Dilution	11.02%	11.02%	-46.80%	23.24%	-32.68%	-2.51%
Total Shareholder Return	11.02%	11.02%	-46.80%	23.31%	-32.24%	-2.51%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.